I. Introduction
Trauma has become the leading cause of death for age productive men dan continues to be the cause of years of life lost compares to cancer, heart disease, and stroke combined. 1 In Indonesia, trauma is the third leading cause of death after coronary heart disease and tuberculosis. 2 Trauma compromise the patient's physiology and potentially cuase dysfunction of uninjured organs. 3 Trauma alters the immune response of SIRS, induces organ dysfunction, and even leads to multiple organ failure. 1, 4 Thoracoabdominal trauma has great contribution to mortality of patients due to its anatomical position. 5 Thoracoabdominal region,which most impact is, contains vital body organs, and oftenly without any visible skin injury. 5 Blunt thoracic trauma oftenly shows no superficial injury, so does blunt abdominal trauma. But, these traumas transfer energy to the internal organs and may cause undetectable fatal effects and poor outcome. 5 Thoracic trauma can cause potential threat to airway, breathing and circulation to the injured patient, that affect clinical outcome of the patient. 6 Bleeding and infection are the potential threat of abdominal trauma. Abdominal trauma can be difficult to evaluate even in hospital setting. 7 Early prognosis evaluation of multitrauma patient is difficult.Clinical parameters which reflect patient's actual condition is required. 4 Previous clinical parameters for evaluating prognosis, such as urine
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DOI: 10.9790/0853-1607016771 www.iosrjournals.org 68 | Page production, oxygen saturation, blood gas analysis, C-reactive protein, base excess have limited function, since they emerged after organ disruption. 4 Previous studies found that there were increasing level of procalcitonin in trauma patients. 4, 8, 9, 10 It had peak concentration after trauma on the first and third day. 4 It is thought that procalcitonin can be used to observe inflammatory status on trauma patients. 11 The role of procalcitonin in thoracoabdominal trauma has never been observed.
II. Material And Methods
This research was prospective. It has been done for four months. Subjects were patients suffered from thoracoabdominal trauma who were admitted. The inclusion criteria were thoracoabdominal trauma patients who were admitted within 24 hours after trauma, age within 18-60 years old, ISS ≥ 16, never underwent operative procedure due to the trauma before admission. Whereas the exclusion criteria were having metabolic abnormality, BMI ≥ 25. The confounding variables for the research were antibiotic and anti-inflammatory administrations, and performed operative procedure within 3 days sincetrauma.
Sampling technique for this research were consecutive. Blood samples were drawn twice. First, was within 24 hours after the trauma. Second, was 72 hours after the trauma. The statistical analysis used for the research was Product Noment Pearson correlation test.
Results
During the research, 53 subjects were collected. They were 46 male and 7 female. Three patients were dropped out becausethey died before the third day. Among 50 subjects, 25 subjects suffered from SIRS with 5 deaths, and 25 subjects were free from SIRS. Patients suffered from SIRS were included in statistical analysis. SIRS suffered deaths had high ISS score (over 40) and low PS score (<60%). Patients suffered from SIRS were included in statistical analysis. Among 53 subjects, 3 subjects (6%) had procalcitonin baseline level of < 2 ng/dL, whereas 50 subjects (94%) had procalciotonin baseline level of > 2 ng/dL. 
Picture 3. Characteristic of subjects (Event of SIRS).
The results were mean value of PCT level in the first day was 11.178± SD 11.568, which was significantly increased in the third day 13.998 ± SD 14.496 with t value of -4.012, with level of significancy 0.001 (Table 2) . Table 2 . Mean value of procalcitonin levels of patients with SIRS.
Picture 4. Mean value of procalcitonin level of patients with SIRS.
The mean PCT level of deceased patients from the first day was 25.98 ± SD 13.47 which was significantly increased in the third day 25.98 ± SD 16.74, with t value of -4.119, with level of significancy 0.05 (Table 3 ). Deceased SIRS patients had significantly higher procalcitonin level compared to survived SIRS patients, as is shown in picture 5.
Tabel 3. Procalcitonin level of deceased SIRS patients.

Picture 5.
Chart showing comparison of procalcitonin levels in survived and deceased SIRS patients.
The result was, patients whose procalcitonin level increased on day three sample, would experience SIRS.
Pearson correlation test was used to evaluatethe relation between increasing level of procalcitonin with SIRS. The test revealed r counting was 0.708 with level of significancy 0.000, which means that, the more increasing level of PCT, the chance for SIRS will also increasing. 
III. Discussion
This study resulted that patients who had increasing level of procalcitonin on the second sampling, would experienced SIRS. The increasing level of procalcitonin is suggested due to expanding tissue damage during trauma. Tissue damage promotes the release of inflammatory mediators. Inflammatory mediators such as TNF-α, IL-1β, IL-6 will resist endopeptidase. The function of endopeptidase is to alter procalcitonin to calcitonin. Since the function of endopeptidase is resisted, the proteolysis of procalcitonin is also resisted, resulted in increasing level of procalcitonin.
The amount of inflammatory mediators will correlate with the patient's inflammatory response. The increasing level of procacitonin from the first to second sample indicates the loads of proinflammatory mediators comparable with body's inflammatory response.
The increasing level of procalcitonin observed during this research is able to be used as early predictor of SIRS in thoracoabdominal trauma patients. Procalcitonin can also be used as an early predictor of morbidity. Procalcitonin monitoring is expected as marker for hyperinflamation in trauma patients, which is useful to consider definitive surgical procedure post trauma.
IV. Conclusion
Trauma causes tissue damage which will then stimulates the release of inflammatory mediators. These inflammatory mediators will induce the the amount of procalcitonin through the inhibition of endopeptidase. Extensive tissue damage will cause large inflammatory mediators release, and further, procalcitonin existence. Hence, procalcitonin can be used as early predictor of SIRS in thoracoabdominal trauma patients.
